Breadcrumb
In 2006, Shinya Yamanaka described a method for reprogramming fibroblasts to embryonic stem cells by defined factors, termed induced pluripotent stem cell (iPSC) reprogramming. Since then, iPSC have been achieved by other methods to include mRNA transfection and episomal expression vectors that rely on application of exogenous nucleic acids. mRNA based reprogramming is desirable for its non-integrating approach and versatility in daily mRNA dosing that may be finely tuned to overcome experimental challenges with potential gains in iPSC quality and efficiency.



